Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.
Quick Stats
Jan 30, 202651.7
AI Score
HOLD0.95
Volume Ratio
Next Earnings
11
+ve Days (30d)
14
-ve Days (30d)
BOLD Stock Summary
Last updated Jan 30, 2026
BOLD is currently trading at $1.16, positioned below its 200-day moving average of $1.24, suggesting bearish momentum. The stock has a 52-week range of $1 to $2.54.
Technical Analysis: The 50-day moving average stands at $1.19, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 38.321, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.157, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates BOLD at 51.7/100 with a HOLD recommendation.
BOLD (Boundless Bio, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 38.321 |
| CMF (20) | -0.157 |
| ROC (10) | -7.2 |
| ADX (14) | 13.25 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.006 |
| AROONOSC (14) | -100.0 |
| WILLAMS %R (14) | -85.714 |
| MFI (14) | 46.016 |
BOLD Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
BOLD Price vs Max Options Open Interest
BOLD Max Change In Options Open Interest
BOLD Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
BOLD Daily Out of Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
BOLD Daily In the Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
BOLD Most Active Options by Volume(near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Boundless Bio, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
BOLD Moving Averages Analysis
BOLD (Boundless Bio, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 1.22 |
| 20 | 1.24 |
| 30 | 1.23 |
| 50 | 1.19 |
| 100 | 1.23 |
| 200 | 1.24 |
BOLD Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 26.0 million |
| Earnings/Share ($) | -2.66 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -2.47 |
| EPS Estimate Next Year ($) | -2.1033 |
| WallStreet Target Price ($) | 3 |
| Most Recent Quarter |